RFK Jr.’s vaccine committee advises Merck’s RSV shot for babies - NewsNation


6/26/2025

RFK Jr.’s vaccine committee advises Merck’s RSV shot for babies  NewsNationRFK Jr’s vaccine panel recommends new RSV treatment for infants  The GuardianACIP Recommends Use of Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season  Merck.comRFK Jr.'s CDC vaccine panel backs Merck RSV shot for infants  CNBCACIP’s New Class Endorses RSV, Talks COVID  Medscape...

Original

Tags: age | cdc | class | committee | disease | for | in | lower | months | new | rfk | rsv | shot | talks | treatment | virus



Let us know what you think!

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

Leave a Comment

Scroll back to top